Both in Pharmaceuticals
RenovoRx vs Verrica Pharmaceuticals
Over the past year RNXT returned +18.5% and VRCA returned −3.9%; their daily moves had a correlation of 0.07.
RNXT +18.5% VRCA −3.9%Growth of $1, one year, split-adjusted
| Metric | RNXT | VRCA |
|---|---|---|
| Price | $1.29 | $3.42 |
| Market cap | $58.3M | $58.7M |
| Today | +2.55% | +6.54% |
| 1 month | −12.1% | −20.7% |
| 6 months | +39.2% | −52.2% |
| Year to date | +53.8% | −58.8% |
| 1 year | +16.4% | −5.3% |
| Revenue growth (YoY) | +115.4% | −53.8% |
| Gross margin | 84.3% | 85.0% |
| Net margin | −320.2% | −224.4% |
| P/E (TTM) | — | — |
| Price / sales | 29.5× | 1.9× |
| Net cash | $9.5M | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 108.4% | 64.1% |
| Short % of float | 2.0% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).